Hrosz will transition from being Sanofi’s general manager, Consumer Healthcare business in Brazil to his new role in India as soon as the a...

"In these roles, he has led the strategic reorientation of the organisation, sharpening its focus on core areas, developing new business mo...

Encube Ethicals has agreed to buy popular topical anti-microbial brand Soframycin and other brands from French drugmaker Sanofi for India a...

Sanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which th...

An expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine develope...

The investment will be made by Sanofi-Synthelabo India "through a combination of primary and secondary funding," Apollo Hospitals said.

Under the proposed deal, Sanofi-Synthelabo would acquire 20 per cent stake and exercise certain rights in relation to management of Apollo ...

Jean-Paul Agon added that L'Oreal would not shrink from a larger takeover, but such a deal would have to make sense and be affordable.

Drug firm Sanofi India today said it has inked a pact with Suzlon Energy for a 2.1 megawatt windmill installation.

Sanofi India announced that it has signed an agreement with India's largest wind turbine manufacturer, SEL, for a 2.1 MW offsite windmill i...

French drug maker Sanofi says it is considering an India-specific strategy to increase its share in the country’s Rs 65,000-crore drug mark...

Income tax authorities summoned the management of Hyderabad based Shanta Biotechnics in connection with an outstanding tax demand of Rs 105...

The shareholders of the company had earlier approved the name change at the annual general meeting held on May 3, a company statement said.

Aventis Pharma said it will acquire the branded nutraceutical formulations business of Mumbai-based Universal Medicare Pvt Ltd.

French pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving the off...

Hyderabad-based Shantha Biotechnics has bagged a USD 340 million (around Rs 1,650 crore) order from Unicef to supply its 'SHAN5', a combina...

India may be a possible location as a global manufacturing base for vaccines business of Sanofi-Aventis Group.